Parker Waichman LLP

Flagging Byetta Sales Force Job Cuts at Amylin

Safety concerns surrounding the diabetes drug Byetta have slowed its sales, forcing Amylin Pharmaceuticals to cut a quarter of its work force. Byetta, which is jointly marketed by Amylin and Eli Lilly, was approved by the Food & Drug Administration (FDA) in 2005 to help type 2 diabetics better control blood sugar when other drugs […]

Safety concerns surrounding the diabetes drug <"https://www.yourlawyer.com/topics/overview/byetta_pancreatitis">Byetta have slowed its sales, forcing Amylin Pharmaceuticals to cut a quarter of its work force.

Byetta, which is jointly marketed by Amylin and Eli Lilly, was approved by the Food & Drug Administration (FDA) in 2005 to help type 2 diabetics better control blood sugar when other drugs were not adequate. The twice-daily injection is a synthetic form of a lizard hormone that boosts the production of insulin. Insulin is vital to controlling blood sugar levels.

Amylin sales have been disappointing all year.  Then, on August 18, the FDA said that Byetta had been linked to 6 cases of hemorrhagic or necrotizing pancreatitis in patients taking Byetta since its October alert. All patients required hospitalization, two patients died and four patients were recovering at time of reporting. Byetta was discontinued in all 6 cases.  Then, on August 26, Amylin announced that four additional fatalities had been confirmed in Byetta patients suffering from milder forms of pancreatitis.

The problems with Byetta have  raised doubts about Amylin’s ability to assure approval of a long-acting version of the drug.  The new version of Byetta would be taken once-weekly.  Because  of its long-acting nature, once-weekly Byetta cannot be quickly removed from the body, which would be a problem for a patient who developed pancreatitis.  In most instances where Byetta patients develop pancreatitis, the problem subsides once treatment is halted.  That would not likely be the case with the long-acting version.

In a filing with the Securities and Exchange Commission (SEC) earlier this month, Amylin revealed that the FDA had rejected data from studies meant to show that new Byetta batches made by partner Alkermes were equivalent to batches made at Amylin’s Ohio facility. If Amylin has to conduct an additional study, it would likely delay its plans to ask for approval by the middle of 2009.

The layoffs announced by Amylin this week involve 340 staffers, and will leave the San Diego company with 1800 employees.  Amylin says the move will save $100 million a year.

In a statement, Amylin said it expects Byetta sales to rebound, and the company is currently working with the FDA to update the drug’s safety labeling.  Amylin is hoping the safety update will not take the form of a black box – the FDA’s toughest safety warning – which could further depress sales of Byetta.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Parker Waichman was extremely professional and helpful in handling our WTC case. Benita Rollis, in particular, was amazing in helping us complete all the necessary steps and paper work for our claim. She was always quick to return phone calls and reach out to keep us posted on how things were progressing. Not only was Benita efficient and professional, she was also very compassionate in helping us through the emotional side of this long process. Carolyn Corcoran & Family
Robert Harris
a year ago
5 Star Reviews 150
Positive: Professionalism I was pleased with how they handled my case from beginning to end. They were also very good with providing information and returning calls.
Daisy Figueroa
2 years ago
5 Star Reviews 150
Nicole Copertino is the BEST. She is very knowledgeable and helpful. She give a clear understanding of your claim and takes the time to give a caring extra moment if u need it. Which means a lot.
NINA DEAN
2 weeks ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038